NanoString Technologies (NASDAQ:NSTG) issued an update on its FY18 earnings guidance on Wednesday morning. The company provided EPS guidance of (2.90)-($2.60) for the period, compared to the Thomson Reuters consensus EPS estimate of ($2.48).
NanoString Technologies (NASDAQ:NSTG) traded down $0.08 during midday trading on Wednesday, reaching $6.93. 912,396 shares of the company’s stock traded hands, compared to its average volume of 234,452. The company has a debt-to-equity ratio of 1.22, a current ratio of 3.40 and a quick ratio of 2.84. NanoString Technologies has a 1 year low of $5.87 and a 1 year high of $20.70. The company has a market capitalization of $172.49, a price-to-earnings ratio of -3.73 and a beta of 0.91.
NanoString Technologies (NASDAQ:NSTG) last posted its quarterly earnings results on Wednesday, March 7th. The biotechnology company reported ($0.34) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.42) by $0.08. NanoString Technologies had a negative net margin of 37.91% and a negative return on equity of 129.90%. The firm had revenue of $35.20 million for the quarter, compared to analyst estimates of $31.57 million. During the same period in the prior year, the firm posted ($0.55) earnings per share. The company’s quarterly revenue was up 39.7% compared to the same quarter last year. sell-side analysts expect that NanoString Technologies will post -2.79 EPS for the current fiscal year.
Several analysts have issued reports on NSTG shares. ValuEngine lowered shares of NanoString Technologies from a sell rating to a strong sell rating in a research report on Friday, February 2nd. Zacks Investment Research raised shares of NanoString Technologies from a hold rating to a buy rating and set a $8.25 price target on the stock in a research report on Wednesday, January 3rd. Finally, Morgan Stanley reaffirmed an equal weight rating and set a $12.00 price target (down from $13.00) on shares of NanoString Technologies in a research report on Thursday, March 8th. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the company. NanoString Technologies presently has a consensus rating of Hold and an average price target of $13.06.
COPYRIGHT VIOLATION WARNING: This story was published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this story on another website, it was copied illegally and republished in violation of US & international copyright law. The original version of this story can be read at https://ledgergazette.com/2018/03/14/nanostring-technologies-nstg-issues-fy18-earnings-guidance.html.
NanoString Technologies Company Profile
NanoString Technologies, Inc develops, manufactures and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Company is engaged in the development, manufacture and commercialization of instruments, consumables and services for profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample.
Receive News & Ratings for NanoString Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies and related companies with MarketBeat.com's FREE daily email newsletter.